Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Phiex Technologies Inc. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action represents the company's active workload at the patent office, reflecting a highly focused intellectual property strategy. The matter is assigned to 1 distinct examiner, which centralizes the review of the company's technology under a single individual's assessment.
The portfolio's activity is concentrated in 1 distinct art unit, suggesting a specific technical niche within the biotech sector. PURDY, KYLE A is the busiest examiner for the portfolio, handling 1 pending office action. Because this 1 action is the only one pending for the company, the examiner's individual review style and technical understanding will directly shape the outcome of the company's current filing. This level of concentration is typical for specialized portfolios where a single key technology is being protected through a targeted prosecution effort.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PURDY, KYLE A | 1 | 41.0% | +35.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18633246 | LIGHT-ACTIVATED CHLORINE DIOXIDE-RELEASING POWDER | PURDY, KYLE A | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18633246 | LIGHT-ACTIVATED CHLORINE DIOXIDE-RELEASING POWDER | PURDY, KYLE A | 1611 | §103 | Final Rejection | 4d overdue | Pending | Apr 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial